Atrion Quick Ratio (ATRI) starting from the second quarter 2024 to second quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Atrion Corporation  (NASDAQ: ATRI)

Atrion's Quick Ratio

ATRI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Atrion's Cash & cash equivalent grew by 121.88 % in the Q2 2024 sequentially, faster than Current Liabilities, this led to improvement in Atrion's Quick Ratio to 0.35, Quick Ratio remained below Atrion Corporation average.

Within Medical Equipment & Supplies industry 146 other companies have achieved higher Quick Ratio than Atrion in second quarter 2024. While Quick Ratio total ranking in the second quarter 2024 has deteriorated compared to the prior quarter from 1982 to 2449.

Explain Quick Ratio?
How much Cash & cash equivalents ATRI´s has?
What are ATRI´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ATRI Quick Ratio (Jun 30 2024)
Q2		 (Mar 31 2024)
Q1		 (Dec 31 2023)
Q4		 (Sep 30 2023)
Q3		 (Jun 30 2023)
Q2
Y / Y Current Liabilities Change 6.75 % -28.65 % 620.83 % -14.61 % -14.76 %
Y / Y Cash & cash equivalent Change 19.33 % -78.79 % -62.06 % -91.9 % -93.12 %
Quick Ratio MRQ 0.35 0.23 0.23 0.25 0.31
ATRI's Total Ranking # 2449 # 1982 # 1941 # 1740 #
Seq. Current Liabilities Change 43.14 % -71.84 % 185.01 % -7.07 % -4.33 %
Seq. Cash & cash equivalent Change 121.88 % -71.89 % 155.77 % -25.19 % -60.56 %



Quick Ratio second quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 147
Healthcare Sector # 745
Overall Market # 2449


Quick Ratio Statistics
High Average Low
7.47 3.91 0.23
(Sep 30 2019)   (Mar 31 2024)




Financial Statements
Atrion's Current Liabilities $ 18 Millions Visit ATRI's Balance sheet
Atrion's Cash & cash equivalent $ 6 Millions Visit ATRI's Balance sheet
Source of ATRI's Sales Visit ATRI's Sales by Geography


Cumulative Atrion's Quick Ratio

ATRI's Quick Ratio for the trailling 12 Months

ATRI Quick Ratio

 (Jun 30 2024)
12 Months		 (Mar 31 2024)
12 Months		 (Dec 31 2023)
12 Months		 (Sep 30 2023)
12 Months		 (Jun 30 2023)
12 Months
Y / Y Current Liabilities TTM Growth 53.99 % 44.89 % 55.58 % -17.67 % -9.6 %
Y / Y Cash & cash equivalent TTM Growth -75.35 % -86.61 % -84.72 % -80.39 % -63.42 %
Quick Ratio TTM 0.25 0.25 0.34 0.87 1.59
Total Ranking TTM # 3651 # 2326 # 2530 # 3091 #
Seq. Current Liabilities TTM Growth 1.27 % -5.33 % 68.26 % -4.54 % -4.71 %
Seq. Cash & cash equivalent TTM Growth 4.6 % -32.24 % -33.56 % -47.66 % -43.17 %

Quick ratio ranking by company, industry and sector >> Back to ATRI Financial Strength Comparisons >> Go to Compare ATRI Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the jump in Current Liabilities in the Q2 2024 to $17.54 millions, cumulative Quick Ratio remained unchanged at 0.25 below the Atrion Corporation average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 220 other companies have achieved higher Quick Ratio than Atrion. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2024 from 2326 to 3651.

Explain Quick Ratio?
How much Cash & cash equivalents ATRI´s has?
What are ATRI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 221
Healthcare Sector # 973
Within the Market # 3651


trailing twelve months Quick Ratio Statistics
High Average Low
6.83 3.83 0.29
(Sep 30 2019)   (Jun 30 2024)




Companies with similar Quick Ratio in the quarter ending Jun 30 2024, within Medical Equipment & Supplies Industry Quick RatioJun 30 2024 MRQ Cash & cash equivalentJun 30 2024 MRQ Current Liabilities
Neuroone Medical Technologies Corp  0.96 $ 1.620  Millions$ 1.691  Millions
Vaso Corporation  0.96 $ 25.652  Millions$ 26.836  Millions
Privia Health Group Inc   0.91 $ 387.352  Millions$ 426.943  Millions
Paragon 28 inc   0.90 $ 46.741  Millions$ 51.691  Millions
Angiodynamics Inc   0.83 $ 76.056  Millions$ 91.155  Millions
Cytosorbents Corporation  0.82 $ 8.459  Millions$ 10.336  Millions
Allurion Technologies Inc   0.82 $ 19.258  Millions$ 23.558  Millions
Solventum Corporation  0.81 $ 897.000  Millions$ 1,106.000  Millions
Becton Dickinson And Company  0.81 $ 5,338.000  Millions$ 6,605.000  Millions
Inari Medical Inc   0.79 $ 109.672  Millions$ 138.261  Millions
Edap Tms Sa  0.79 $ 33.416  Millions$ 42.348  Millions
Medtronic Plc  0.76 $ 7,843.000  Millions$ 10,287.000  Millions
Sharecare Inc   0.75 $ 85.151  Millions$ 113.928  Millions
Embecta Corp   0.74 $ 275.100  Millions$ 370.700  Millions
Innovage Holding Corp   0.74 $ 102.779  Millions$ 138.599  Millions
Orthopediatrics Corp  0.73 $ 28.927  Millions$ 39.569  Millions
Streamex Corp   0.71 $ 2.104  Millions$ 2.976  Millions
West Pharmaceutical Services Inc   0.70 $ 446.200  Millions$ 633.700  Millions
Pro dex Inc   0.70 $ 6.848  Millions$ 9.810  Millions
Sonoma Pharmaceuticals Inc   0.69 $ 2.589  Millions$ 3.751  Millions
Nuo Therapeutics Inc   0.69 $ 0.473  Millions$ 0.690  Millions
Icu Medical Inc  0.59 $ 302.648  Millions$ 511.907  Millions
Sharps Technology Inc   0.58 $ 1.483  Millions$ 2.553  Millions
Tenon Medical Inc   0.58 $ 1.968  Millions$ 3.403  Millions
Dexcom Inc   0.56 $ 939.200  Millions$ 1,685.900  Millions
Zimvie Inc   0.56 $ 78.601  Millions$ 141.124  Millions
Sanara Medtech Inc   0.53 $ 6.150  Millions$ 11.566  Millions
Boston Scientific Corporation  0.52 $ 2,913.000  Millions$ 5,576.000  Millions
Align Technology inc   0.52 $ 782.111  Millions$ 1,511.521  Millions
Pavmed Inc   0.49 $ 25.499  Millions$ 52.021  Millions

Date modified: 2024-09-15T09:08:20+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.